.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Elke Müller

Jena, DE

Leibniz Institute of Photonic Technology e.V. Jena (Leibniz-IPHT)

Vortrag

19.09.2023
Poster
PRHYP 296
Design, development and verification of a new lateral flow Assay for the fast and direct detection of PBP2a from clonal cultures of Staphylococcus aureus
IPC and MDRO and nosocomial pathogens (FG PR HY/StAG Hyg)

Weitere Beteiligungen

18.09.2023
Poster
MSP 163
Protein microarrays as tools for lateral flow development for multiplex beta-lactam and colistin resistance detection
Molecular Infection Epidemiology and Prediction of Antimicrobial Resistance (FG MS)
19.09.2023
14:45 – 15:00 10 Min. 5 Min.
Vortrag
MVV 095
Characterisation of PVL-positive Staphylococcus argenteus from the United Arab Emirates
Viruses of Microbes: From basic research to application (FG MV)
19.09.2023
Poster
PRHYP 296
Design, development and verification of a new lateral flow Assay for the fast and direct detection of PBP2a from clonal cultures of Staphylococcus aureus
IPC and MDRO and nosocomial pathogens (FG PR HY/StAG Hyg)